Methylenedioxy-Methylamphetamine MDMA

4 reviews for Methylenedioxy-Methylamphetamine MDMA

1. 

   Rated 5 out of 5

   Octavio H. Monier – May 28, 2020

   Aims of the study were to find the prevalence of female depression, and to study the differences between female and male depression, in private practice. Four hundred forty eight consecutive unipolar and bipolar II depressed outpatients were interviewed with the Structured Clinical Interview for DSM-IV, the Montgomery Asberg Depression Rating Scale, and the Global Assessment of Functioning scale.

2. 

   Rated 5 out of 5

   Barbara B. Smith – June 28, 2020

   Animals were evaluated in the light/dark test 30 min after injection of MDMA (1, 8, and 15 mg/Kg I.p) or saline. The following parameters were recorded (for 5 min): (a) number of exploratory rearings in the light and dark sections; (b) number of transitions between the lit and dark areas; (c) time spent in the light and dark areas; (d) latency of the initial movement from the light to the dark area, and (e) locomotor activity in light area.

3. 

   Rated 5 out of 5

   Hugo V. Barrow – June 28, 2020

   The effects of acute administration of 3,4-methylenedioxymethamphetamine (MDMA; “ecstasy”) on anxiety tested in the light/dark box were examined in albino male mice of the OF.1 strain.

4. 

   Rated 5 out of 5

   Dorothy M. Dickinson – October 28, 2020

   MDMA (8 and 15 mg/kg) produced a significant reduction in exploratory activity (rearings and transitions), without decreasing motility, in comparison with saline- treated mice. However, time spent in lit/dark compartments was not significantly affected by the drug, which could be a consequence of the anti-exploratory properties of MDMA.